Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
AstraZeneca PLC ADR TradeGate Stock Price Today | NASDAQ AZNPy Live Ticker - Investing.com
Investing.com· 2 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 2 days agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
World-First Trial Shows Benefits of Finding, Treating Undiagnosed Asthma, COPD
MedPage Today· 2 days agoIdentifying symptomatic individuals in the community with undiagnosed asthma and chronic obstructive...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 7 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased ...
Astra’s Enhertu delays breast cancer in patients with low HER2 levels
WSAU Wausau· 5 days agoBy Deena Beasley (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 12 hours agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoEmpaveli recorded sales of $25.6 million in the reported quarter, up 25.5% from the year-ago...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 1 day agoSenderovitz is working with partners from other pharmaceutical companies, including James...